This updates a previous post about Fresenius, the company that provides Dialysis Support for me and thousands of others.
Fresenius Medical Care is a German company specializing in providing dialysis products and services. The company was founded in 1996 as a result of the merger of Fresenius AG and the American company National Medical Care. However, the roots of the company’s involvement in the dialysis business can be traced back to the 1960s.
In 1966, Fresenius AG was founded in Germany as a pharmaceutical company. In the early 1970s, the company began manufacturing dialysis machines and equipment, and by the mid-1970s, Fresenius had become one of the leading suppliers of dialysis equipment in Europe.
In 1987, Fresenius acquired a controlling stake in National Medical Care (NMC), a US-based dialysis company. NMC was founded in 1971 by Dr. Stanley Shaldon and was one of the largest dialysis providers in the United States at the time of its acquisition. Fresenius gained a significant presence in the US dialysis market through the acquisition.
In 1996, Fresenius AG merged with NMC to form Fresenius Medical Care. The merger created one of the largest dialysis companies in the world, with operations in over 100 countries. Fresenius Medical Care continued to expand its business through acquisitions and partnerships, including the acquisition of Gambro AB in 2013, a Swedish company that specialized in dialysis products and services.
Today, Fresenius Medical Care is one of the leading providers of dialysis products and services globally, with over 3,900 dialysis clinics and a workforce of approximately 120,000 employees. The company’s products and services include dialysis machines, dialyzers, renal pharmaceuticals, and related laboratory and diagnostic services.
In conclusion, Fresenius Medical Care’s involvement in the dialysis business began in the 1960s with the manufacturing of dialysis machines and equipment by Fresenius AG. The acquisition of NMC in 1987 and the subsequent merger with Fresenius AG in 1996 further expanded the company’s presence in the dialysis market, leading to its current position as a leading provider of dialysis products and services worldwide.
In general, employee reviews on websites such as Glassdoor and Indeed suggest that Fresenius Medical Care is a good place to work, with many employees citing good benefits, supportive colleagues, and opportunities for career growth. However, some reviews also mention a high workload and demanding job responsibilities, which may be expected given the nature of the healthcare industry.
In terms of industry recognition, Fresenius Medical Care has received several awards and accolades as an employer. In 2020, the company was named one of the “World’s Most Admired Companies” by Fortune magazine and was recognized as a “Best Place to Work for LGBTQ Equality” by the Human Rights Campaign Foundation.
Fresenius Medical Care has also received recognition for its commitment to diversity and inclusion in the workplace. In 2020, the company was named a “Top 50 Employer” by the National Association of Female Executives and was recognized as a “Best Employer for Diversity” by Forbes magazine.
Overall, while individual experiences may vary, Fresenius Medical Care appears to be a company that values its employees and strives to create a supportive and inclusive workplace culture.
Fresenius Medical Care is publicly traded on several stock exchanges, including the Frankfurt Stock Exchange in Germany and the New York Stock Exchange in the United States. The company’s stock symbol is FME in Germany and FMS in the United States.
Historically, Fresenius Medical Care has performed well in the stock market, with steady growth in share price over the years. For example, between 2016 and 2020, the company’s share price in Germany increased from around €70 to over €80 per share. In the United States, the company’s share price increased from around $43 to over $50 per share during the same period.
Leave a Reply